ArticleVaccines2021

Comparing the Clinical and Economic Outcomes Associated with Adjuvanted versus High-Dose Trivalent Influenza Vaccine among Adults Aged ≥ 65 Years in the US during the 2019-20 Influenza Season-A Retrospective Cohort Analysis.

Myron J Levin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.